Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination

Renal Failure

Volumn 28, Issue 2, 2006, Pages 125-128

  Basturk, T ^a   Altuntas Y ^a   Kurklu, A ^a   Aydin, L ^a   Eren, N ^a   Unsal, A ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Diabetic nephropathy; Earlier marker; Perindopril indapamide combination; Urinary NAG

Indexed keywords

3 CRESOLSULPHONPHTHALEIN; ALBUMIN; CREATININE; HEMOGLOBIN A1C; INDAPAMIDE; N ACETYL BETA GLUCOSAMINIDASE; N ACETYLGLUCOSAMINE; PERINDOPRIL; PHTHALEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION RETINOPATHY; KIDNEY FAILURE; LOW DRUG DOSE; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PATIENT CODING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INDAPAMIDE; MALE; MIDDLE AGED; PERINDOPRIL;

EID: 33645550266     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500530510     Document Type: Article

References (14)

1. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease. More than an aftermath of glomerular injury? Kidney Int. 1999;56:1627-1637.
2. Price RG. Measurement of N-acetyl B glucosaminidase and its isoenzymes in urine. Methods and clinical applications. Eur J Clin Biochem. 1992;30:693-705.
3. Gunder WG, Hofmann W. Marker for the diagnosis and monitoring of renal tubular lesions. Clin Nephrol. 1992;38:3-7.
4. Perdichizzi G, Cucinotta D, Fera R, Di Cesare E, Campo S. Correlation between urinary activity of N-acetyl-B-D glucosaminidase and albumin excretion rate in type II diabetic subjects. Acta Diabetol Lat. 1987;24:149-155.
5. Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabet Complications. 1998;12(1):43-60.
6. Kordonouri O, Hartmann R, Müller C, Danne T, Weber B. Predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes. Horm Res. 1998;50(suppl 1):23-27.
7. Kato H, Takashima T, Kishikawa H, Emura S, Ommori K. The significance of urinary N-acetyl B-D-glucosaminidase for predicting early stage diabetic nephropathy. Int J Pract. 1997;51(8):489-490.
8. Jung K, Pergande M, Schimke E, Ratzmann KP, Ilius A. Urinary enzymes and low molecular mass proteins as indicators of diabetic nephropathy. Clin Chem. 1998;34:544-547.
9. Perez-Blanco FJ, Sabatel Hernandez G, Cantero Hinojosa J, Rodriguez-Cuartero A. Urinary N-acetyl beta-glucosaminidase excretion in non-insulin dependent diabetes mellitus: relation with diabetic nephropathy. Clin Nephrol. 1998;49:132-134.
10. Fujita H, Narita T, Morii T, et al. Increased urinary excretion of N-acetylglucosaminidase in subjects with impaired glucose tolerance. Ren Fail. 2002;24:69-75.
11. Zatz R, Dunn BR, Meyer TW, Brenner B. Prevention of diabetic glomerulopathy by pharmocological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-1930.
12. Gilbert RE, Cox A, Wu LL, et al. Expession of transforming growth factor B1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of angiotensin converting enzyme inhibition. Diabetes. 1998;47:414-422.
13. Ravid M, Brosh D, Levi Z, Bardayan Y, Ravid D, Rachmani R. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus - a randomized, controlled trial. Ann Intern Med. 1998;128:982-988.
14. Mocan Z, Erem C, Yildirim M, Telatar M, Deger O. Urinary beta2 microglobulin and urinary N-acetyl beta-glucosaminidase enzyme activities in early diagnosis of non-insulin dependent diabetes mellitus nephropathy. Diabetes Res. 1994;26:101-107.